These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 31213801)
1. Prolonged retention of liposomes in the pleural cavity of normal mice and high tumor distribution in mice with malignant pleural effusion, after intrapleural injection. Marazioti A; Papadia K; Giannou A; Stathopoulos GT; Antimisiaris SG Int J Nanomedicine; 2019; 14():3773-3784. PubMed ID: 31213801 [No Abstract] [Full Text] [Related]
2. Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed. Ando H; Kobayashi S; Abu Lila AS; Eldin NE; Kato C; Shimizu T; Ukawa M; Kawazoe K; Ishida T J Control Release; 2015 Dec; 220(Pt A):29-36. PubMed ID: 26476173 [TBL] [Abstract][Full Text] [Related]
3. Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion. Li X; Wu G; Chen C; Zhao Y; Zhu S; Song X; Yin J; Lv T; Song Y Front Immunol; 2021; 12():760683. PubMed ID: 34966384 [TBL] [Abstract][Full Text] [Related]
4. [Therapeutical effects of pleural injecting recombinant human endostain to malignant pleural effusion nude mice model]. Zhou M; Li M; Yang H; Hu C Zhongguo Fei Ai Za Zhi; 2015 May; 18(5):266-71. PubMed ID: 25975296 [TBL] [Abstract][Full Text] [Related]
5. The Safety and Exploration of the Pharmacokinetics of Intrapleural Liposomal Curcumin. Hocking A; Tommasi S; Sordillo P; Klebe S Int J Nanomedicine; 2020; 15():943-952. PubMed ID: 32103948 [TBL] [Abstract][Full Text] [Related]
6. Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions. Perez-Soler R; Shin DM; Siddik ZH; Murphy WK; Huber M; Lee SJ; Khokhar AR; Hong WK Clin Cancer Res; 1997 Mar; 3(3):373-9. PubMed ID: 9815694 [TBL] [Abstract][Full Text] [Related]
8. Intrapleural nano-immunotherapy promotes innate and adaptive immune responses to enhance anti-PD-L1 therapy for malignant pleural effusion. Liu Y; Wang L; Song Q; Ali M; Crowe WN; Kucera GL; Hawkins GA; Soker S; Thomas KW; Miller LD; Lu Y; Bellinger CR; Zhang W; Habib AA; Petty WJ; Zhao D Nat Nanotechnol; 2022 Feb; 17(2):206-216. PubMed ID: 34916656 [TBL] [Abstract][Full Text] [Related]
9. Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis. Lombardi G; Nicoletto MO; Gusella M; Fiduccia P; Dalla Palma M; Zuin A; Fiore D; Donach M; Zagonel V Cancer Chemother Pharmacol; 2012 Mar; 69(3):781-7. PubMed ID: 22037881 [TBL] [Abstract][Full Text] [Related]
10. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge. Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629 [TBL] [Abstract][Full Text] [Related]
11. Monitoring with a non-invasive bioluminescent in vivo imaging system of pleural metastasis of lung carcinoma. Matsumoto S; Tanaka F; Sato K; Kimura S; Maekawa T; Hasegawa S; Wada H Lung Cancer; 2009 Oct; 66(1):75-9. PubMed ID: 19178977 [TBL] [Abstract][Full Text] [Related]
12. A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion. Stathopoulos GT; Psallidas I; Moustaki A; Moschos C; Kollintza A; Karabela S; Porfyridis I; Vassiliou S; Karatza M; Zhou Z; Joo M; Blackwell TS; Roussos C; Graf D; Kalomenidis I J Natl Cancer Inst; 2008 Oct; 100(20):1464-76. PubMed ID: 18840818 [TBL] [Abstract][Full Text] [Related]
13. [The effect of intrapleural pingyangmycin administration on activity of fibrinolytic system and transforming growth factor-beta1 in malignant pleural effusion]. Zhu QQ; Sun GY Zhonghua Jie He He Hu Xi Za Zhi; 2009 Sep; 32(9):674-8. PubMed ID: 20079281 [TBL] [Abstract][Full Text] [Related]
16. Engineered lactococcus lactis intrapleural therapy promotes regression of malignant pleural effusion by enhancing antitumor immunity. Fan Y; Chen A; Zhu J; Liu R; Mei Y; Li L; Sha X; Wang X; Ren W; Wang L; Liu B Cancer Lett; 2024 Apr; 588():216777. PubMed ID: 38432582 [TBL] [Abstract][Full Text] [Related]
17. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer. Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723 [TBL] [Abstract][Full Text] [Related]
18. Intrapleural Trastuzumab Therapy for Malignant Pleural Effusion from HER2 Overexpression in Metastatic Gastric Cancer. Orlandi E; Mordenti P; Zangrandi A; Cavanna L Chemotherapy; 2014; 60(5-6):321-4. PubMed ID: 26279275 [TBL] [Abstract][Full Text] [Related]
19. Influence of lymphocytes in malignant pleural effusion on the therapeutic efficacy of intrapleural OK-432 in lung cancer patients. Shimizu T; Takahashi N; Terakado M; Akusawa H; Tsujino I; Horie T Intern Med; 2006; 45(11):715-20. PubMed ID: 16819251 [TBL] [Abstract][Full Text] [Related]